The NICE menopause guidelines were produced to help non-specialist drs as well as women be more informed and make the best choice for treatment. Like all Nice guidelines, they are published after extensive consultation with a range of specialists and researchers.
They key part of these, re. HRT or ADs, is that HRT is the first line of therapy when mood disorders coincide with peri or post menopause and there is no previous history of depression or extenuating life events at the same time.
This latter problem is at its worst in the few years before the cessation of periods – the transition phase. This subgroup of depressive disorders is called Reproductive Depression (RD) and are important because the causation is endocrine rather than psychiatric and the most effective and logical treatment is by hormones rather than antidepressants.
The NICE guidelines say this:
Ensure that menopausal women and healthcare professionals involved in their care understand that there is no clear evidence for SSRIs or SNRIs to ease low mood in menopausal women who have not been diagnosed with depression (see the NICE guideline on depression in adults)
They also suggest CBT and other talking therapies as a first-line treatment, with HRT.
ADs are suitable as a treatment for hot flushes for women who cannot use HRT due to previous or current disease, such as cancer.
Many GPs prescribe ADs because they are not confident about the right HRT to offer, or they have not kept up to date with the research on HRT which has replaced the discredited research, which exaggerated the risks.
It's never been proved that HRT causes high blood pressure. Women with high BP can use HRT as long as they are treated for high BP at the same time. Obviously high BP can occur during periods of stress which may be caused by mood swings due to hormonal changes.
There is plenty of evidence that HRT improves arterial health and subsequently heart health, by measurement of the carotid artery and lipds in women using HRT.